LUSC clinical samples and cell lines

YM Yuanyuan Ma
BK Bin Kang
SL Shaolei Li
GX Guoyun Xie
JB Jiwang Bi
FL Fuqiang Li
GA Guo An
BL Bing Liu
JL Jing Li
YS Yue Shen
XX Xun Xu
HY Huanming Yang
YY Yue Yang
YG Ying Gu
NW Nan Wu
request Request a Protocol
ask Ask a question
Favorite

A total of 150 case samples using paraffin sections for the immunohistochemistry assay and 3 case samples from fresh tumor tissues and corresponding normal tissues for cell viability assay were collected from LUSC patients who had undergone resection at the Department of Thoracic Surgery II of the Peking University Cancer Hospital & Institute. Informed consent was obtained from all of the participants with the approval of the ethics committee in Peking University Cancer Hospital & Institute.

The LUSC cell lines H520 and SKMES-1 were obtained from the American Type Culture Collection, and EBC-1 was retrieved from Deutsche Sammlung von Mikroorganismen und Zellkulturen. These cells were maintained in RPMI-1640 or DMEM medium with 10% fetal bovine serum (FBS) (Thermo Fisher Scientific) in 5% CO2 at 37°C. After cleaning any mycoplasma contamination, the cell lines were authenticated using polymorphic short tandem repeat loci analyses.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A